Joshua N. Silverman - 22 Dec 2021 Form 4 Insider Report for Petros Pharmaceuticals, Inc. (PTPI)

Role
Director
Signature
/s/ Mitchell Arnold, attorney-in-fact
Issuer symbol
PTPI
Transactions as of
22 Dec 2021
Net transactions value
$0
Form type
4
Filing time
07 Jan 2022, 15:45:04 UTC
Previous filing
29 Nov 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTPI Restricted Stock Units Award $0 +25,156 $0.000000 25,156 22 Dec 2021 Common Stock 25,156 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer.
F2 The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date

Remarks:

Exhibit Index: Exhibit 24.1 Power of Attorney (furnished herewith)